Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
B1395 Sulfacetamide SodiumSummary: Sulfonamide antibiotic -
B1391 Divalproex SodiumSummary: Epilepsy/migraines/bipolar disorder medicine -
B3515 DUBs-IN-2Summary: deubiquitinase enzyme inhibitor -
B3516 DUBs-IN-3Summary: potent deubiquitinase enzyme inhibitor -
B3701 FPH1 (BRD-6125)1 CitationSummary: Hepatocyte functional proliferation enhancer -
B7535 Eeyarestatin ITarget: ERADSummary: inhibitor of endoplasmic reticulum-associated degradation (ERAD) and protein translocation -
B7637 SMER 28Summary: Positive regulator of autophagy -
B7727 NSC 624206Summary: Ubiquitin-activating enzyme (E1) inhibitor -
B7745 SZL P1-41Summary: Skp2 inhibitor -
A8179 MG-2623 CitationTarget: ProteasomeSummary: Proteasome inhibitor

